Document is current
Any future updates will be listed below
-
Authors
Howie, Alison H.
Tingley, Kylie
Inbar-Feigenberg, Michal
Mitchell, John J.
Angel, Kim
Gentle, Jenifer
Smith, Maureen
Offringa, Martin
Butcher, Nancy J.
Campeau, Philippe M.
Chakraborty, Pranesh
Chan, Alicia
Fergusson, Dean
Mamak, Eva
McClelland, Peyton
Mercimek-Andrews, Saadet
Mhanni, Aizeddin
Moazin, Zeinab
Rockman-Greenberg, Cheryl
Rupar, C. Anthony
Skidmore, Becky
Stockler, Sylvia
Thavorn, Kednapa
Wyatt, Alexandra
Potter, Beth K. https://orcid.org/0000-0001-8374-6542
,
-
Funding
Funding for this research was provided by:
Canadian Institutes of Health Research (171684)
- License Information
-
More Information
Article History
Received: 8 November 2023
Accepted: 17 September 2024
First Online: 23 October 2024
Declarations
:
: Not applicable.
: Not applicable.
: Michal Inbar-Feigenberg has worked with pharmaceutical companies that market products for the treatment of Mucopolysaccharidoses. This relationship did not have any impact on the design or review of this paper. The other authors declare that they have no competing interests from companies that have a financial stake in the findings from this study.
